
Compugen Ltd
NASDAQ:CGEN

Compugen Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.18
2.57
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Compugen Ltd hold over its rivals?
What risks and challenges
does Compugen Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Compugen Ltd.
Provide an overview of the primary business activities
of Compugen Ltd.
What unique competitive advantages
does Compugen Ltd hold over its rivals?
What risks and challenges
does Compugen Ltd face in the near future?
Summarize the latest earnings call
of Compugen Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Compugen Ltd.
Provide P/S
for Compugen Ltd.
Provide P/E
for Compugen Ltd.
Provide P/OCF
for Compugen Ltd.
Provide P/FCFE
for Compugen Ltd.
Provide P/B
for Compugen Ltd.
Provide EV/S
for Compugen Ltd.
Provide EV/GP
for Compugen Ltd.
Provide EV/EBITDA
for Compugen Ltd.
Provide EV/EBIT
for Compugen Ltd.
Provide EV/OCF
for Compugen Ltd.
Provide EV/FCFF
for Compugen Ltd.
Provide EV/IC
for Compugen Ltd.
Show me price targets
for Compugen Ltd made by professional analysts.
What are the Revenue projections
for Compugen Ltd?
How accurate were the past Revenue estimates
for Compugen Ltd?
What are the Net Income projections
for Compugen Ltd?
How accurate were the past Net Income estimates
for Compugen Ltd?
What are the EPS projections
for Compugen Ltd?
How accurate were the past EPS estimates
for Compugen Ltd?
What are the EBIT projections
for Compugen Ltd?
How accurate were the past EBIT estimates
for Compugen Ltd?
Compare the revenue forecasts
for Compugen Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Compugen Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Compugen Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Compugen Ltd compared to its peers.
Compare the P/E ratios
of Compugen Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Compugen Ltd with its peers.
Analyze the financial leverage
of Compugen Ltd compared to its main competitors.
Show all profitability ratios
for Compugen Ltd.
Provide ROE
for Compugen Ltd.
Provide ROA
for Compugen Ltd.
Provide ROIC
for Compugen Ltd.
Provide ROCE
for Compugen Ltd.
Provide Gross Margin
for Compugen Ltd.
Provide Operating Margin
for Compugen Ltd.
Provide Net Margin
for Compugen Ltd.
Provide FCF Margin
for Compugen Ltd.
Show all solvency ratios
for Compugen Ltd.
Provide D/E Ratio
for Compugen Ltd.
Provide D/A Ratio
for Compugen Ltd.
Provide Interest Coverage Ratio
for Compugen Ltd.
Provide Altman Z-Score Ratio
for Compugen Ltd.
Provide Quick Ratio
for Compugen Ltd.
Provide Current Ratio
for Compugen Ltd.
Provide Cash Ratio
for Compugen Ltd.
What is the historical Revenue growth
over the last 5 years for Compugen Ltd?
What is the historical Net Income growth
over the last 5 years for Compugen Ltd?
What is the current Free Cash Flow
of Compugen Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Compugen Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
IL |
![]() |
Compugen Ltd
NASDAQ:CGEN
|
146.8m USD | -3 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 280.1 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
150.2B USD | 16.2 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
140.5B USD | 20.6 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW | 32.3 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39.1B CHF | 22.6 |
|
JP |
D
|
DNA Chip Research Inc
TSE:2397
|
6.8T JPY | 69 428.2 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
32.8B USD | 19.1 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
26.9B USD | 11.3 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
188.5B CNY | 16.1 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
24B USD | 21 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
IL |
![]() |
Compugen Ltd
NASDAQ:CGEN
|
Average EV/EBITDA:
7 086.8
|
N/A | N/A | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 280.1
|
7%
|
182.9 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
16.2
|
6%
|
2.7 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
20.6
|
7%
|
2.9 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
32.3
|
17%
|
1.9 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
22.6
|
18%
|
1.3 |
|
JP |
D
|
DNA Chip Research Inc
TSE:2397
|
69 428.2
|
N/A | N/A |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
19.1
|
10%
|
1.9 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
11.3
|
9%
|
1.3 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
16.1
|
24%
|
0.7 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
21
|
4%
|
5.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.